REYNOLDS MARK (CFO) purchased 94.3% of their position (6.80K shares) of GEOVAX LABS, INC. on the open market
Open‑market purchase worth $7.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/31/2025ACC: 0001437749-25-010179
+6.80K
Net shares
Net buyer
$7.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6.80K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.80K
Price / share
$1.08
Trade value
$7.34K
% of position
94.3%
3/31/2025
7.21K→14.01K
Total
Net shares
+6.80K
Net value
$7.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2025 | P · Purchase | +6.80K | $1.08 | $7.34K | 94.3% | 7.21K | 14.01K |
| Total | +6.80K | $7.34K | ||||||
Derivative Transactions0
No derivative transactions reported